HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen Li Selected Research

Karen Li Research Topics

Disease

12Necrotizing Enterocolitis
01/2021 - 06/2006
11Sepsis (Septicemia)
01/2019 - 03/2002
7Inflammation (Inflammations)
01/2021 - 09/2010
7Neoplasms (Cancer)
12/2020 - 06/2004
5Infections
01/2007 - 03/2002
3Ischemic Stroke
09/2020 - 07/2007
3Leukemia
01/2020 - 12/2003
3Intestinal Perforation
03/2016 - 01/2012
3Hypoxia (Hypoxemia)
01/2015 - 10/2005
3Cardiomyopathies (Cardiomyopathy)
09/2013 - 01/2009
3Myocardial Infarction
09/2013 - 10/2011
2Heart Arrest (Cardiac Arrest)
01/2022 - 01/2022
2Brain Diseases (Brain Disorder)
12/2020 - 10/2005
2Stroke (Strokes)
09/2020 - 11/2019
2Dementia (Dementias)
06/2018 - 01/2018
2Cognitive Dysfunction
06/2018 - 01/2018
2Bacterial Infections (Bacterial Infection)
02/2013 - 03/2002
2Cardiotoxicity
10/2011 - 05/2006
2Body Weight (Weight, Body)
09/2010 - 01/2006
2Hemolysis
08/2008 - 11/2006
2Thrombocytopenia (Thrombopenia)
08/2004 - 09/2003
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Aphasia (Dysphasia)
12/2020
1Lymphoma (Lymphomas)
12/2020
1Brain Edema (Cerebral Edema)
12/2020
1Brain Ischemia (Cerebral Ischemia)
01/2020
1Neonatal Sepsis
01/2019
1Hepatitis B
01/2016
1Tuberculosis (Tuberculoses)
01/2016
1Infarction (Infarctions)
10/2011
1Hemolytic Anemia
10/2011
1Mucoepidermoid Carcinoma
01/2011
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2011
1Lung Neoplasms (Lung Cancer)
01/2011
1Hyperglycemia
09/2010
1Obesity
09/2010
1Hypoglycemia (Reactive Hypoglycemia)
09/2010
1Adenocarcinoma
11/2009

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2010
6Interleukin-6 (Interleukin 6)IBA
01/2018 - 03/2002
6CytokinesIBA
02/2013 - 12/2002
5Proteins (Proteins, Gene)FDA Link
12/2013 - 06/2004
5Doxorubicin (Adriamycin)FDA LinkGeneric
09/2013 - 05/2006
4MicroRNAs (MicroRNA)IBA
01/2020 - 01/2015
4C-Reactive ProteinIBA
01/2018 - 03/2002
3Arginine (L-Arginine)FDA Link
03/2016 - 12/2014
3Thrombopoietin (c-mpl Ligand)IBA
09/2013 - 05/2006
3Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2009 - 11/2006
2Chimeric Antigen ReceptorsIBA
12/2020 - 01/2019
2Biological ProductsIBA
11/2019 - 02/2003
2Messenger RNA (mRNA)IBA
01/2015 - 06/2004
2Interleukin-12 (IL 12)IBA
02/2013 - 12/2003
2Interleukin-15 (Interleukin 15)IBA
02/2013 - 12/2003
2Dexrazoxane (Zinecard)FDA LinkGeneric
10/2011 - 01/2009
2elemeneIBA
01/2011 - 11/2009
2Interleukin-10 (Interleukin 10)IBA
01/2007 - 06/2006
2InterleukinsIBA
01/2007 - 12/2003
2ChemokinesIBA
01/2007 - 06/2006
2Chemokine CCL5IBA
01/2007 - 06/2006
1Androgen Receptor AntagonistsIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1enzalutamideIBA
01/2022
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1NFI Transcription FactorsIBA
01/2021
1GTP-Binding Proteins (G-Protein)IBA
01/2021
1axicabtagene ciloleucelIBA
12/2020
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2020
1IntegrinsIBA
01/2020
1Integrin alpha4beta1 (VLA-4)IBA
01/2020
1Circulating MicroRNAIBA
01/2019
1Indicators and Reagents (Reagents)IBA
06/2018
1Vitamin DFDA LinkGeneric
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2016
1EnzymesIBA
03/2016
1Transcription Factors (Transcription Factor)IBA
01/2015
1Toll-Like Receptor 4IBA
01/2015
1Trefoil Factor-3IBA
12/2013
1Fatty Acid-Binding ProteinsIBA
12/2013
1cardiogeninIBA
01/2012
1Therapeutic UsesIBA
01/2012
1naphthaleneIBA
10/2011
1NF-kappa B (NF-kB)IBA
01/2011
1Glucagon (Glukagon)FDA Link
09/2010
1Insulin (Novolin)FDA Link
09/2010
1Glucagon-Like Peptide-2 ReceptorIBA
09/2010
1Glucose (Dextrose)FDA LinkGeneric
09/2010
1Apolipoprotein C-II (ApoC2)IBA
08/2010
1Edetic Acid (EDTA)FDA Link
08/2009
1AntioxidantsIBA
01/2009

Therapy/Procedure

3Therapeutics
01/2019 - 12/2003
2Thrombectomy
09/2020 - 01/2020
2Transplantation
07/2007 - 01/2006
1Induced Hypothermia
01/2022
1Drug Therapy (Chemotherapy)
01/2022
1Immunotherapy
01/2020
1Cognitive Training
01/2018
1Drug Prescriptions
01/2016
1Oral Administration
01/2012
1Aftercare (After-Treatment)
10/2011